Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin II-treated and untreated rats

Nephron - Physiology

Volumn 98, Issue 4, 2004, Pages

  Ishizaka, Nobukazu ^a   Saito, Kan ^a   Noiri, Eisei ^a   Sata, Masataka ^a   Mori, Ichiro ^b   Ohno, Minoru ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Ferritin; Heme oxygenase 1; Iron overload; Proteinuria

Indexed keywords

ANGIOTENSIN; FERRIC FERROCYANIDE; FERRITIN; HEME OXYGENASE 1; IRON; IRON DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; FERRITINS; HEME OXYGENASE (DECYCLIZING); IRON; IRON OVERLOAD; IRON-DEXTRAN COMPLEX; KIDNEY; KIDNEY DISEASES; MALE; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 11244253747     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081559     Document Type: Article

References (24)

1. Bruzzi I, Benigni A, Remuzzi G: Role of increased glomerular protein traffic in the progression of renal failure. Kidney Int Suppl 1997;62:S29-S31.
2. Nankivell BJ, Boadle RA, Harris DC: Iron accumulation in human chronic renal disease. Am J Kidney Dis 1992;20:580-584.
3. Baliga R, Ueda N, Shah SV: Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 1993;291:901-905.
4. Ishiyama A, Atarashi K, Minami M, et al: Role of free radicals in the pathogenesis of lipidinduced glomerulosclerosis in rats. Kidney Int 1999;55:1348-1358.
5. Van Den Branden C, Deman A, Ceyssens B, et al: Vitamin E protects renal antioxidant enzymes and attenuates glomerulosclerosis in adriamycin-treated rats. Nephron 2002;91:129-133.
6. Baliga R, Zhang Z, Baliga M, et al: In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998;53:394-401.
7. Zhou XJ, Laszik Z, Wang XQ, et al: Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 2000;80:1905-1914.
8. Ishizaka N, Aizawa T, Yamazaki I, et al: Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest 2002;82:87-96.
9. 2α with different pressor dependencies in rats. Hypertension 2002;39:149-154.
10. Aizawa T, Ishizaka N, Taguchi J, et al: Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: Possible role in renoprotection. Hypertension 2000;35:800-806.
11. Saito K, Ishizaka N, Mitani H, et al: Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett 2003;551:58-62.
12. Ishizaka N, de Leon H, Laursen JB, et al: Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 1997;96:1923-1929.
13. Obejero-Paz CA, Yang T, Dong WQ, et al: Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy. J Lab Clin Med 2003;141:121-130.
14. Mitani H, Ishizaka N, Aizawa T, et al: In vivo klotho gene transfer ameliorates angiotensin IIinduced renal damage. Hypertension 2002;39:838-843.
15. Dahdah K, Patrie JT, Bolton WK: Intravenous iron dextran treatment in predialysis patients with chronic renal failure. Am J Kidney Dis 2000;36:775-782.
16. Legssyer R, Geisser P, McArdle H, et al: Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress. Biometals 2003;16:425-433.
17. Otterbein L, Chin BY, Otterbein SL, et al: Mechanism of hemoglobin-induced protection against endotoxemia in rats: A ferritin-independent pathway. Am J Physiol 1997;272:L268-275.
18. Aizawa T, Ishizaka N, Taguchi J, et al: Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery. Biochem Biophys Res Commun 1999;261:302-307.
19. Zager RA: Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 1992;90:711-719.
20. Nath KA, Balla G, Vercellotti GM, et al: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992;90:267-270.
21. Gonzalez-Michaca L, Farrugia G, Croatt AJ, et al: Heme: A determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 2004;286:F370-377.
22. Nath KA, Vercellotti GM, Grande JP, et al: Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 2001;59:106-117.
23. Ishizaka N, Aizawa T, Mori I, et al: Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol 2000;279:H672-H678.
24. Brink M, Price SR, Chrast J, et al: Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 2001;142:1489-1496.